Charles River Collaborates with Fios Genomics for Bioinformatics-Driven Drug Discovery and Safety Assessment

 Charles River Collaborates with Fios Genomics for Bioinformatics-Driven Drug Discovery and Safety Assessment

Charles River Collaborates with Fios Genomics for Bioinformatics-Driven Drug Discovery and Safety Assessment

Shots:

  • The collaboration provides Charles River’s client access to Fios Genomics’ expertise in bioinformatics, statistics and biology, assisting the sourcing and analysis datasets associated with the drug development including microarrays, NGS, proteomics, metabolomics, epigenetics and associated meta-data
  • The agreement merges Fios’ biologically-relevant insights with Charles River’s drug discovery and development platform and the scientific expertise of both the companies
  • The focus of the agreement is to accelerate preclinical, discovery and development by turning complex data into actionable information. Charles River’s clients will be able to make data-driven decisions about their programs thus leading to an improvement in speed

Click here to­ read full press release/ article | Ref: Charles River | Image: Mayo news

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post